CD276 and Ewing sarcoma: CAR T-cells targeting B7-H3 (CD276), a checkpoint molecule highly expressed on pediatric solid tumor and brain tumors, have been generated for use in preclinical orthotopic xenograft models of osteosarcoma, Ewing sarcoma, and medulloblastoma.